Stock Update (NYSE:BAX): Coherus BioSciences and Baxter Announce Amendment to Etanercept Biosimilar Collaboration Agreement

[GlobeNewswire] – REDWOOD CITY, Calif. and DEERFIELD, Ill. — Coherus BioSciences, Inc. and Baxter International Inc. today announced that they have amended certain financial terms of their collaboration agreement established … Read more . . . → Read More: Stock Update (NYSE:BAX): Coherus BioSciences and Baxter Announce Amendment to Etanercept Biosimilar Collaboration Agreement Similar Articles: Company Update (NASDAQ:AMGN): Amgen to appeal rejection of bid to block Novartis biosimilar drug Company Update (NYSE:BAX): CTI BioPharma And Baxter Announce Positive Top-Line Results From Phase 3 Persist-1 Trial Of Pacritinib For Patients With Myelofibrosis Market Update (NYSE:BAX): Baxter’s BioScience Business Acquires Biopharmaceutical Company SuppreMol